RPGRIP1-Like (RPGRIP1L) (N-Term) Peptide
RPGRIP1L
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all RPGRIP1L products
- RPGRIP1L (RPGRIP1-Like (RPGRIP1L))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- HARKQEDKIK RMATKLIRLV NDKKRYERVG GGPKRLGRDV EMEEMIEQLQ
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-FTM Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
RPGRIP1-Like (RPGRIP1L) peptide
RPGRIP1L Reactivity: Human, Dog Host: Synthetic BP, Imm
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- RPGRIP1L (RPGRIP1-Like (RPGRIP1L))
- Background
-
The protein encoded by this gene can localize to the basal body-centrosome complex or to primary cilia and centrosomes in ciliated cells. The encoded protein has been found to interact with nephrocystin-4. Defects in this gene are a cause of Joubert syndrome type 7 (JBTS7) and Meckel syndrome type 5 (MKS5). Two transcript variants encoding different isoforms have been found for this gene.
Alias Symbols: RPGRIP1L,FTM,KIAA1005,NPHP8,
Protein Size: 1315 - Gene ID
- 23322
- NCBI Accession
- NP_056087
- UniProt
- Q68CZ1
-
You are here:
